Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, B-Cell, Marginal Zone × capivasertib × 90 days × Clear all

Sponsor

Conditions

Breast Neoplasms 10 Triple Negative Breast Neoplasms 3 Disease Progression 2 Prostatic Neoplasms 1 Neoplasms 1 Neoplasm Metastasis 1 Moderate Hepatic Impairment 1 Meningioma 1 Melanoma 1 Lymphoma 1 Leukemia 1 Healthy Participants 1 Exanthema 1 Diarrhea 1

Interventions

Rituximab 19 Cyclophosphamide 13 Lenalidomide 10 zanubrutinib 8 fludarabine 8 venetoclax 5 fludarabine phosphate 5 pirtobrutinib 4 orelabrutinib 4 Vincristine 4 obinutuzumab 3 Whole-Body Irradiation 3 Specimen Handling 3 Prednisone 3 Magnetic Resonance Spectroscopy 3 Doxorubicin 3 CT-P10 3 ibrutinib 2 Therapeutics 2 Radiation 2 Mycophenolic Acid 2 Maintenance 2 Leukapheresis 2 Immunotherapy, Adoptive 2 Granulocyte Colony-Stimulating Factor 2 Cyclosporine 2 Biopsy 2 Bendamustine Hydrochloride 2 voruciclib 1 treosulfan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡